logo-loader
ASX:PTX

Prescient Therapeutics Ltd

Receive alerts
Market:
ASX
Market Cap:
$23.66 m
Price
0.06 AUD
Change
-4.76%
52 weeks high
0.15
52 weeks low
0.02

In brief

Prescient Therapeutics Ltd (ASX:PTX) is a clinical stage oncology company developing personalised medicine approaches to cancer, including targeted and cellular therapies.